Exelon Corp: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 11, 2020 and accepted by EDGAR at Feb 11, 2020, 16:02 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-10-01 to 2019-12-31 | $8.34bn | us-gaap:Revenues |
| Revenue | 12 months2019-01-01 to 2019-12-31 | $34.44bn | us-gaap:Revenues |
| Operating income | 3 months2019-10-01 to 2019-12-31 | $962.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $4.37bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $1.59bn | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $774.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-10-01 to 2019-12-31 | $773.0m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 12 months2019-01-01 to 2019-12-31 | $3.03bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | $0.79 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $3.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-10-01 to 2019-12-31 | $0.79 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $3.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 974,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $6.66bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $7.25bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $1.41bn | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2019-12-31 | $587.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $12.04bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $124.98bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $14.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $90.40bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $31.33bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $4.71bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2019-12-31 | $1.37bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-12-31 | $32.22bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001109357-20-000053. Last ingested by Listed: Nov 14, 2026, 14:06 ET. Listed shows no prices and gives no investment advice.